{"organizations": [], "uuid": "d88ef68d853bb684ae53f9c0077facb0ad309932", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-portola-pharmaceuticals-announces/brief-portola-pharmaceuticals-announces-results-of-chmp-oral-explanations-for-andexanet-alfa-and-betrixaban-idUSFWN1QA12S", "country": "US", "domain_rank": 408, "title": "BRIEF-Portola Pharmaceuticals Announces Results Of CHMP Oral Explanations For Andexanet Alfa And Betrixaban", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-20T23:51:00.000+02:00", "replies_count": 0, "uuid": "d88ef68d853bb684ae53f9c0077facb0ad309932"}, "author": "", "url": "https://www.reuters.com/article/brief-portola-pharmaceuticals-announces/brief-portola-pharmaceuticals-announces-results-of-chmp-oral-explanations-for-andexanet-alfa-and-betrixaban-idUSFWN1QA12S", "ord_in_thread": 0, "title": "BRIEF-Portola Pharmaceuticals Announces Results Of CHMP Oral Explanations For Andexanet Alfa And Betrixaban", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 20 (Reuters) - Portola Pharmaceuticals Inc:\n* PORTOLA PHARMACEUTICALS ANNOUNCES RESULTS OF CHMP ORAL EXPLANATIONS FOR ANDEXANET ALFA AND BETRIXABAN\n* PORTOLA PHARMA SAYS COMMITTEE FOR CHMP OF EMA COMMUNICATED POSITIVE TREND VOTE ON MARKETING AUTHORISATION APPLICATION FOR ANDEXANET ALFA Source text for Eikon: Further company coverage:\n ", "external_links": [], "published": "2018-02-20T23:51:00.000+02:00", "crawled": "2018-02-21T00:13:50.002+02:00", "highlightTitle": ""}